Progranulin protein levels are differently regulated in plasma and CSF
暂无分享,去创建一个
R. Petersen | B. Boeve | D. Knopman | R. Roberts | M. Mielke | N. Finch | N. Rutherford | Aleksandra M. Wojtas | Alexandra M. Nicholson | Colleen S. Thomas | Nicola J. Rutherford | R. Rademakers | D. Knopman | R. Roberts
[1] A. Tura,et al. Circulating progranulin levels in women with gestational diabetes mellitus and healthy controls during and after pregnancy. , 2012, European journal of endocrinology.
[2] Robert V Farese,et al. Suberoylanilide Hydroxamic Acid (Vorinostat) Up-regulates Progranulin Transcription , 2011, The Journal of Biological Chemistry.
[3] K. Sleegers,et al. Rescue of Progranulin Deficiency Associated with Frontotemporal Lobar Degeneration by Alkalizing Reagents and Inhibition of Vacuolar ATPase , 2011, The Journal of Neuroscience.
[4] H. Feldman,et al. rs5848 polymorphism and serum progranulin level , 2011, Journal of the Neurological Sciences.
[5] Allissa Dillman,et al. Genome-wide screen identifies rs646776 near sortilin as a regulator of progranulin levels in human plasma. , 2010, American journal of human genetics.
[6] H. Feldman,et al. Sortilin-Mediated Endocytosis Determines Levels of the Frontotemporal Dementia Protein, Progranulin , 2010, Neuron.
[7] E G Tangalos,et al. Prevalence of mild cognitive impairment is higher in men , 2010, Neurology.
[8] Olle Melander,et al. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus , 2010, Nature.
[9] M. J. Fresnadillo Martínez,et al. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions , 2010, Nature Genetics.
[10] K. Sleegers,et al. Serum biomarker for progranulin‐associated frontotemporal lobar degeneration , 2009, Annals of neurology.
[11] R. Petersen,et al. Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members , 2009, Brain : a journal of neurology.
[12] G. Binetti,et al. Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration , 2008, Neurology.
[13] R. Petersen,et al. Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia , 2008, Human molecular genetics.
[14] P. Carmeliet,et al. Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival , 2008, The Journal of cell biology.
[15] V. Pankratz,et al. The Mayo Clinic Study of Aging: Design and Sampling, Participation, Baseline Measures and Sample Characteristics , 2008, Neuroepidemiology.
[16] R. Petersen. Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.
[17] K. Blennow,et al. Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice. , 2001, Archives of neurology.
[18] A. Bateman,et al. Cellular Localization of Gene Expression for Progranulin , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[19] M. Emmerling,et al. High levels of circulating Abeta42 are sequestered by plasma proteins in Alzheimer's disease. , 1999, Biochemical and biophysical research communications.
[20] E. Matsubara,et al. Lipoprotein‐free amyloidogenic peptides in plasma are elevated in patients with sporadic Alzheimer's disease and Down's syndrome , 1999, Annals of neurology.
[21] S. Hirai,et al. Longitudinal study of cerebrospinal fluid levels of tau, Aβ1–40, and Aβ1–42(43) in Alzheimer's disease: A study in Japan , 1998 .
[22] E. Oguni,et al. Amyloid β protein in plasma from patients with sporadic Alzheimer's disease , 1996, Journal of the Neurological Sciences.
[23] Hans Förstl,et al. Analysis of Heterogeneous βA4 Peptides in Human Cerebrospinal Fluid and Blood by a Newly Developed Sensitive Western Blot Assay* , 1996, The Journal of Biological Chemistry.
[24] R. Wolfert,et al. Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease , 1995 .
[25] D. Galimberti,et al. Gender effects on plasma PGRN levels in patients with Alzheimer's disease: a preliminary study. , 2013, Journal of Alzheimer's disease : JAD.
[26] J. Molinuevo,et al. Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer's disease: detection of GRN mutations in a Spanish cohort. , 2012, Journal of Alzheimer's disease : JAD.
[27] S. Steinberg,et al. Progranulin is a potential prognostic biomarker in advanced epithelial ovarian cancers. , 2011, Gynecologic oncology.
[28] J. Hodges,et al. Low serum progranulin predicts the presence of mutations: a prospective study. , 2010, Journal of Alzheimer's disease : JAD.
[29] S. Hirai,et al. Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan. , 1998, Annals of neurology.
[30] E. Oguni,et al. Amyloid beta protein in plasma from patients with sporadic Alzheimer's disease. , 1996, Journal of the neurological sciences.
[31] D. Galasko,et al. Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease. , 1995, Annals of neurology.